Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
212.10
-0.70 (-0.33%)
At close: Apr 13, 2026
Market Cap188.02B -1.9%
Revenue (ttm)81.95B +13.4%
Net Income25.95B +16.0%
EPS29.27 +16.0%
Shares Out886.45M
PE Ratio7.25
Forward PE6.58
Dividend12.00 (5.66%)
Ex-Dividend DateNov 17, 2025
Volume229,857
Average Volume265,713
Open213.50
Previous Close212.80
Day's Range212.00 - 214.20
52-Week Range198.00 - 236.00
Beta0.11
RSI44.99
Earnings DateApr 29, 2026

About DSE:SQURPHARMA

Square Pharmaceuticals PLC., together with its subsidiaries, manufactures, markets, and distributes pharmaceutical products in Bangladesh and internationally. The company offers pharmaceutical products comprising alimentary preparations, amoebocides, analgesics, anthelmintics, anti-aphthous ulcer, anti-erectile dysfunction, anti-gout, anti-hyperkalemia, anti-osteoarthritis, anti-thyroid, anti-ulcerants, antiallergies, antianemics, antiasthma, antibiotics, antidiabetics, antifibrinolytics, antihemorrhoidals, antihistamines, antiosteoporotics, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1958
Employees 15,937
Stock Exchange Dhaka Stock Exchange
Ticker Symbol SQURPHARMA
Full Company Profile

Financial Performance

In fiscal year 2025, DSE:SQURPHARMA's revenue was 76.29 billion, an increase of 8.83% compared to the previous year's 70.10 billion. Earnings were 23.97 billion, an increase of 14.54%.

Financial Statements